Your browser doesn't support javascript.
loading
Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection?
Reddy, Neha V; Yeh, Hsin-Chieh; Tronieri, Jena S; Stürmer, Til; Buse, John B; Reusch, Jane E; Johnson, Steven G; Wong, Rachel; Moffitt, Richard; Wilkins, Kenneth J; Harper, Jeremy; Bramante, Carolyn T.
Afiliación
  • Reddy NV; Division of General Internal Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN.
  • Yeh HC; Departments of Medicine, Epidemiology and Oncology, Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD.
  • Tronieri JS; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Stürmer T; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Buse JB; Division of Endocrinology, Department of Medicine, University of North Carolina Medical School, Chapel Hill, NC.
  • Reusch JE; University of Colorado Denver Anschutz Medical Campus, Denver, CO.
  • Johnson SG; Institute for Health Informatics, University of Minnesota, Minneapolis, MN.
  • Wong R; Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY.
  • Moffitt R; Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY.
  • Wilkins KJ; Biostatistics Program, Office of the Director, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD.
  • Harper J; Owl HealthWorks, Indianapolis, IN.
  • Bramante CT; Division of General Internal Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN.
medRxiv ; 2022 Dec 04.
Article en En | MEDLINE | ID: mdl-36482974
ABSTRACT
Long-term sequelae of severe acute respiratory coronavirus-2 (SARS-CoV-2) infection may include an increased incidence of diabetes. Our objective was to describe the temporal relationship between new diagnoses of diabetes mellitus and SARS-CoV-2 infection in a nationally representative database. There appears to be a sharp increase in diabetes diagnoses in the 30 days surrounding SARS-CoV-2 infection, followed by a decrease in new diagnoses in the post-acute period, up to 360 days after infection. These results underscore the need for further investigation, as understanding the timing of new diabetes onset after COVID-19 has implications regarding potential etiology and screening and treatment strategies.

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2022 Tipo del documento: Article